[1]
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China; China Medical Science and Technology Press: Beijing, 2015.
[7]
Niu, X.P. A severe liver damage case induced by Shou Wu Pian though oral administration. Chinese J. New Drugs Clin Rem., 1996, 15, 382-386.
[13]
Wang, Z.Z. Potential liver damage induced by Polygonum multiflorum and its set prescription preparation. Yaoxue Fuwu Yu Yanjiu, 2014, 14(6), S25-S26.
[15]
Lei, X.; Chen, J.; Li, Y.; Zhai, J.B.; Zheng, W.K.; Ren, J.T.; Mu, W.; Zhang, L.; Tian, G.H.; Shang, H.C. Liver damage associated with Polygonum multiflorum Thunb.: A systematic review of case reports and case series. Evid.-Based Complementary Altern. Med., 2015, 459749.
[16]
Wang, H.; Yang, J.; Zhou, L.Y.; Lou, B.; Cheng, X.X.; Zhang, C.R.; Tang, X.M.; Pan, L.M.; Liu, L.; Yang, Q. Chemical compositions and pharmacological activities of Polygoni multiflori Radix. Chin J Exp Tradit Med Form., 2019, 25(13), 192-205.
[21]
Quan, Y.Y.; Zhou, Y.M.; Liu, M.C.; Li, Y.X. Hepatotoxicity evaluation of eighteen compounds in Polygoni multiflora with zebrafish (Danio rerio) model. Nat Prod Res Dev., 2018, 30, 744-752.
[22]
Song, Q.; Ma, Z.J.; Wang, J.B.; Xiao, X.H.; Zhao, K.J. Study on the effect of Polygonum multiflorum and its main components against L02 cells. Beijing J. Tradit. Chin. Med., 2016, 35(7), 694-697.
[23]
Zhang, L.; Bai, Z.F.; Li, C.Y.; Huhuang, W.Y.; Sha, M.C.; Liu, Z.X.; He, Q.; Li, Y.M.; Liu, Y.P.; Xiao, X.H.; Wang, J.B. Study on idiosyncratic liver injury and content of cis-2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside in radix Polygoni multiflori Preparata. Yao Xue Xue Bao, 2017, 52(7), 1041-1047.
[28]
Gan, H.; Dou, G.F. Advances in research on the reactive metabolites. Int. J. Pharm. Res., 2007, 34(5), 351-355.
[31]
Huang, J.; Zhang, J.P.; Bai, J.Q.; Wei, M.J.; Zhang, J.; Huang, Z.H.; Qu, G.H.; Xu, W.; Qiu, X.H. Chemical profiles and metabolite study of raw and processed Polygoni multiflori Radix in rats by UPLC-LTQ-orbitrap MSn spectrometry. Chin. J. Nat. Med., 2018, 16(5), 0357-0400.
[35]
Lin, P.; Lu, J.M.; Zhang, G.Y.; Li, Y.F.; Geng, C.A.; Chen, J.J.; Yue, J.; Zhao, R.H. Study on absorption and metabolism of active compounds of Polygoni multiflori Radix in hepatic l-02 cells by liquid chromatography tandem-mass spectrometry. Chung Kuo Yao Hsueh Tsa Chih, 2015, 50(12), 1048-1053.
[37]
Pei, Y.H.; Wu, H.H.; Chen, G. Application of metabolomics in hepatotoxicity and nephrotoxicity evaluation of natural medicines. J. Int. Pharm. Res., 2011, 38(5), 329-335.
[39]
Liang, L.; Xu, J.; Zhou, W.W.; Brand, E.; Chen, H.B.; Zhao, Z.Z. Integrating targeted and untargeted metabolomics to investigate the processing chemistry of Polygoni multiflori radix. Front Pharmacol., 2018, 9, 934/1-934/19.
[53]
Meng, Z.J.; Ding, X.S. Recent advances in the study of Polygoni multiflori Radix: its absorbed components in rat blood, pharmacokinetics and metabolomic study of hepatotoxicity. Prog. Pharm. Sci., 2019, 43(5), 379-383.
[55]
Li, C.Y.; Qin, H.; Tang, J.F.; Sha, M.C.; Tu, C.; Zhang, L.; Liu, Z.X.; Wang, J.B.; Xiao, X.H. Metabolomic study on immunological stress-mediated hepatotoxicity of Polygonum multiflorum and its processed products of nine times steaming and nine times sunning. Yao Xue Xue Bao, 2017, 52(7), 1069-1076.
[57]
Jiao, C.L.; Ou, L.; Gao, F.; Yu, J.H.; Miao, F.; Wang, L.P.; Wei, P.F.; Meng, D.L. Plasma metabolomics study on liver injury in kidney-yang deficiency syndrome rats induced by raw and processed Polygonum multiflorum. J. Shenyang Pharm. Univ., 2018, 35(8), 620-627.
[59]
Zhang, L.; Wang, L.Y.; Zhang, K.X.; Wei, G.H.; Yang, Z.G. Metabolomics databases for natural products research and development. Chem. Anal. Meter., 2019, 28, 128-134.